These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8680964)
1. Temporomandibular joint pain as a neuropathy. Zapp JJ; Short S Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Dec; 80(6):621. PubMed ID: 8680964 [No Abstract] [Full Text] [Related]
2. Neurotoxicity of lidocaine combined with mexiletine. Christie JM; Valdes C; Markowsky SJ Anesth Analg; 1993 Dec; 77(6):1291-4. PubMed ID: 8250327 [No Abstract] [Full Text] [Related]
3. [Intravenous lidocaine in the treatment of post treatment neuropathy]. Fukuda H; Kasuda H; Nemoto K; Shimizu R Masui; 1994 Jun; 43(6):941-3. PubMed ID: 8072160 [TBL] [Abstract][Full Text] [Related]
4. The management of oral mexiletine and intravenous lidocaine to treat chronic painful symmetrical distal diabetic neuropathy. Ackerman WE; Colclough GW; Juneja MM; Bellinger K J Ky Med Assoc; 1991 Oct; 89(10):500-1. PubMed ID: 1744511 [TBL] [Abstract][Full Text] [Related]
5. Lidocaine and mexiletine therapy for erythromelalgia. Kuhnert SM; Phillips WJ; Davis MD Arch Dermatol; 1999 Dec; 135(12):1447-9. PubMed ID: 10606048 [No Abstract] [Full Text] [Related]
6. The emerging role of botulinum toxin in the treatment of temporomandibular disorders. Song PC; Schwartz J; Blitzer A Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205 [TBL] [Abstract][Full Text] [Related]
7. [Pathogenetic substantiation of principles of individual combined pharmacotherapy in patients with non-articulation temporomandibular joint dysfunction]. Slesarev OV Stomatologiia (Mosk); 2004; 83(6):44-8. PubMed ID: 15602473 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of familial erythermalgia with the association of lidocaine and mexiletine]. Legroux-Crespel E; Sassolas B; Guillet G; Kupfer I; Dupre D; Misery L Ann Dermatol Venereol; 2003 Apr; 130(4):429-33. PubMed ID: 12843854 [TBL] [Abstract][Full Text] [Related]
9. Lidocaine and oral mexiletine block reflex bronchoconstriction in asthmatic subjects. Zemenick RB Am J Respir Crit Care Med; 1997 Nov; 156(5):1703-4. PubMed ID: 9372699 [No Abstract] [Full Text] [Related]
10. Use of botulinum toxin A for treatment of myofascial pain and dysfunction. Fallah HM; Currimbhoy S J Oral Maxillofac Surg; 2012 May; 70(5):1243-5. PubMed ID: 22538024 [No Abstract] [Full Text] [Related]
11. The effects of collagen hydrolysat on symptoms of chronic fibromyalgia and temporomandibular joint pain. Olson GB; Savage S; Olson J Cranio; 2000 Apr; 18(2):135-41. PubMed ID: 11202824 [TBL] [Abstract][Full Text] [Related]
12. [Oral maintenance treatment with mexiletine after acute administration of xilocaine (author's transl)]. Codecà L; Gruppillo P; Padovan GC; Masoni C; Masoni A G Ital Cardiol; 1981; 11(4):481-4. PubMed ID: 6169579 [No Abstract] [Full Text] [Related]
13. Identifying a neurobiologic basis for drug therapy in TMDs. Denucci DJ; Dionne RA; Dubner R J Am Dent Assoc; 1996 May; 127(5):581-93. PubMed ID: 8642138 [TBL] [Abstract][Full Text] [Related]
14. Trigger point injection therapy in the management of myofascial temporomandibular pain. Ozkan F; Cakır Özkan N; Erkorkmaz U Agri; 2011 Jul; 23(3):119-25. PubMed ID: 21935818 [TBL] [Abstract][Full Text] [Related]
15. Tiagabine may reduce bruxism and associated temporomandibular joint pain. Kast RE Anesth Prog; 2005; 52(3):102-4. PubMed ID: 16252740 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic treatments for temporomandibular disorders. Dionne RA Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Jan; 83(1):134-42. PubMed ID: 9007937 [TBL] [Abstract][Full Text] [Related]
17. [Quality of life as the criterion of psychological status of patients with painful dysfunction of the temporomandibular joint]. Mamedov FM; Markov BP; Gorozhankina EA Stomatologiia (Mosk); 2004; 83(4):65-7. PubMed ID: 15340309 [TBL] [Abstract][Full Text] [Related]
19. Auriculotemporal syndrome after injection into the temporomandibular joint: report of case. Simpson W J Oral Surg; 1968 Sep; 26(9):602-3. PubMed ID: 4299382 [No Abstract] [Full Text] [Related]
20. Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms. Di Rienzo Businco L; Di Rienzo Businco A; D'Emilia M; Lauriello M; Coen Tirelli G Acta Otorhinolaryngol Ital; 2004 Oct; 24(5):279-83. PubMed ID: 15871609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]